Skip to main content
. 2024 Jul 23;12(8):1638. doi: 10.3390/biomedicines12081638

Figure 4.

Figure 4

Medical treatment by patients in groups of patients depending on the dynamics of the haSTART after CABG. Notes: ARBs—Angiotensin II receptor blockers, ACEI—Angiotensin-converting-enzyme inhibitor, CCB—calcium channel blockers; *—significant differences in pairwise comparison of groups with improved haSTART and without changes haSTART; #—significant differences in pairwise comparison of groups with improved haSTART and with worsened haSTART; $—significant differences in pairwise comparison of groups without changes haSTART with worsened haSTART.